The Business Research Company's Key Market Driver In Hepagam B industry 2025: Rising Hepatitis B Prevalence To Fueling Growth It will grow to $XX million in 2029 at a compound annual growth rate (CAGR ...
Hologic (NASDAQ:HOLX – Get Free Report) had its price target lowered by analysts at Citigroup from $80.00 to $70.00 in a ...
Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday after Citigroup ...
Wigan Today on MSN9h
Potential to save more lives with expansion of blood borne virus testing in NHS GM Emergency DepartmentsA successful blood borne virus (BBV) opt-out testing programme is being expanded across NHS Greater Manchester emergency ...
From the column: "Health care providers are battling the storm, on a seemingly impossible quest to repair the tattered mess ...
Zahra Bakhsh said she felt like she’d been “hit by a truck” after finding a letter from Toronto Public Health in her mailbox, informing her she might have been exposed to HIV, hepatitis B, and ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, has entered into privately negotiated exchange and ...
More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback